NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against The Chemours Company (NYSE: CC), Methanex Corporation (NASDAQ: MEOH), and AirSculpt Technologies, Inc. (NASDAQ: AIRS). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

The Chemours Company (NYSE: CC)

On February 13, 2024, after the market closed, Chemours disclosed that it was postponing the release of its financial results and conference call related to its fourth quarter and full year 2023. The Company further clarified, stating that it was delaying its results because Chemours is “evaluating its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to information and communications,” and because the Company’s Audit Committee “needs additional time to complete a related internal review.”

On this news, Chemours’ stock price fell as much as 12% during intraday trading on February 14, 2024, thereby injuring investors.

For more information on the Chemours investigation go to: https://bespc.com/cases/CC

Methanex Corporation (NASDAQ: MEOH)

On February 20, 2024, Methanex issued a press release “announc[ing] . . . that commercial production of its new 1.8 million tonne methanol plant, Geismar 3 (G3), in Geismar, Louisiana has been delayed due to complications that occurred in the autothermal reformer (ATR) during the late stages of the initial start-up process.” Methanex stated that significant damage was sustained to a large number of supporting refractory bricks in the vessel which will require replacement, causing commercial production to be delayed up to the end of the third quarter of 2024.

On this news, Methanex’s stock price fell $5.08 per share, or 10.8%, to close at $41.97 per share on February 20, 2024.

For more information on the Methanex investigation go to: https://bespc.com/cases/MEOH

AirSculpt Technologies, Inc. (NASDAQ: AIRS)

Fuzzy Panda Research issued a report Friday alleging issues at AirSculpt Technologies, Inc. The report states that AirSculpt has “lie[d] to patients” about a patient death, has “[s]uspect doctors with questionable credentials,” and has used employees to “pos[e] as patients” in online reviews. 

Shares of AirSculpt dropped more than 30% in premarket trading on February 23, 2024.

For more information on the AirSculpt investigation go to: https://bespc.com/cases/AIRS

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com